Related Experiment Video
Updated: May 3, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
MicroRNAs 143 and 145 may be involved in benign prostatic hyperplasia pathogenesis through regulation of target genes
Nayara I Viana1, Sabrina T Reis, Nelson G Dip
1Laboratory of Medical Investigation (LIM55), University of Sao Paulo Medical School, Sao Paulo - Brazil.
Objectives:
The aim of this study was to analyze the roles of miR-143 and miR-145, as well as the gene and protein expression of their targets (KRAS, ERK5, MAP3K3, and MAP4K4) in the pathogenesis of benign prostatic hyperplasia (BPH).
Methods:
We analyzed the specimens of 44 patients diagnosed with BPH who underwent surgical treatment. The control group consisted of prostate samples from 2 young patients who were organ donors. miRNAs and their target genes were assessed using real-time polymerase chain reaction (qRT-PCR), and protein levels were assessed by Western blotting.
Results:
miR-143 and miR-145 were overexpressed in, respectively, 62.5% and 73.8% of the cases. The ERK5 and MAP4K4 genes were underexpressed respectively in 59.4% and 100% of the BPH samples, whereas KRAS and MAP3K3 were overexpressed respectively in 79.4% and 61.5% of the samples. Increased protein expression was found for both KRAS (4,312.2 luminance/area) and MAP3K3 (7,461.7 luminance/area), while the ERK5 protein was more abundant in the samples from patients with prostate larger than 60 grams (p=0.019).
Conclusions:
The overexpression of miR-143 and miR-145 in BPH samples suggests an association with the pathogenesis of the disease; additionally, the latter miRNA may act through the inhibition of MAP4K4. KRAS and MAP3K3 overexpression may also be associated with BPH pathogenesis. Further analyses are necessary to confirm these results.
Insights
This study found that miR-143 and miR-145 are overexpressed in benign prostatic hyperplasia (BPH), suggesting a role in the disease. Key target genes KRAS and MAP3K3 also showed increased expression in BPH.
Area of Science:
- Molecular Biology
- Urology
- Oncology
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- The molecular mechanisms underlying BPH pathogenesis are not fully understood.
- MicroRNAs (miRNAs) play crucial roles in gene regulation and are implicated in various diseases.
Purpose of the Study:
- To investigate the roles of miR-143 and miR-145 in BPH pathogenesis.
- To analyze the gene and protein expression of their targets: KRAS, ERK5, MAP3K3, and MAP4K4 in BPH.
Main Methods:
- Analysis of prostate tissue specimens from 44 BPH patients and 2 controls.
- Quantification of miRNA and target gene expression using real-time polymerase chain reaction (qRT-PCR).
- Assessment of protein levels via Western blotting.
Main Results:
- miR-143 and miR-145 were overexpressed in 62.5% and 73.8% of BPH cases, respectively.
- KRAS and MAP3K3 genes were overexpressed in BPH samples (79.4% and 61.5%).
- Increased protein expression of KRAS and MAP3K3 was observed; ERK5 protein was more abundant in larger prostates.
Conclusions:
- Overexpression of miR-143 and miR-145 suggests their association with BPH pathogenesis.
- miR-145 may inhibit MAP4K4, and KRAS and MAP3K3 overexpression could also be linked to BPH.
- Further research is needed to confirm these findings and elucidate the precise mechanisms.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
The Ras Gene
Ras is a...

